Iranian President Mahmoud Ahmadinejad on Tuesday joined a ceremony to unveil indigenously-produced strategic biological medicine.
Iranian President Mahmoud Ahmadinejad has attended a ceremony, held to introduce new strategic biological medicine into the array of the country’s indigenously-produced medications.
During the Tuesday ceremony, which was also attended by Iran's Health Minister Marzieh Vahid-Dastjerdi, eight such types strategic biological medicine were unveiled.
The medications included conjugated hemophilus influenza type B vaccine, used to prevent infantile meningitis, the recombinant factor VIII, used to cure hemophiliacs, and Trastuzumab, also known as Herceptin, used in breast cancer treatment.
Recombinant sex steroid hormone (SSH) used to treat infertility, PTH hormone to treat parathyroid and bone disorders, Etanercept to treat joint problems in arthritis and loperamide to fight prostate cancer and certain infertility problems were among the medications unveiled in the event.
A number of diagnostic kits such as ELIZA and Syphilis ELISA Kits were also introduced during the ceremony.